Brief: NewAmsterdam Pharma Highlights 2024 Achievements And Outlines 2025 Strategic Priorities
10/01/2025 13:24
Jan 10 (Reuters) - NewAmsterdam Pharma Company NV
KH6.F :
* NEWAMSTERDAM PHARMA HIGHLIGHTS 2024 ACHIEVEMENTS AND
OUTLINES
2025 STRATEGIC PRIORITIES
Source text: urn:newsml:reuters.com:*:nGNXbVb0ym
Further company coverage: KH6.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewAmsterdam Pharma
See all newsBrief: Menarini Group & Newamsterdam Pharma Receive European Commission Approval For Ubeslo And Evlarco
Amgen falls after Novartis trial setback, BMO downgrade
Brief: Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Newamsterdam Pharma Company N.V. - Announces Positive CHMP Opinion For Obicetrapib And Obicetrapib/Ezetimibe
Brief: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)